Zevra Therapeutics Inc. (ZVRA)
7.67
0.35 (4.78%)
At close: Apr 02, 2025, 3:59 PM
7.48
-2.54%
After-hours: Apr 02, 2025, 07:34 PM EDT
Zevra Therapeutics Cash Flow Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| Net Income | -105.51M | -46.05M | -41.54M | -8.55M | -12.76M | -24.52M | -56.47M | -43.39M | -16.52M | -54.66M | -24.45M | -5.23M | -70.42K |
| Depreciation & Amortization | 6.39M | 1.01M | 944K | 257K | 273K | 304K | 324K | 336K | 175K | 84K | 74.76K | 68K | 62.56K |
| Stock-Based Compensation | 14.91M | 5.95M | 4.29M | 2.44M | 2.49M | 4.41M | 6.5M | 4.56M | 6.6M | 2.37M | 213.76K | 134K | 467.99K |
| Other Working Capital | -4.63M | 3.63M | 3.03M | -295K | 374K | -5.12M | -650K | -849K | 3.32M | 87K | 523K | -4K | n/a |
| Other Non-Cash Items | 14.55M | 5.55M | 18.05M | 460K | 7.25M | 3.19M | 3.71M | 6.87M | -30.24M | 29.95M | 8.82M | -985K | -4.43M |
| Deferred Income Tax | n/a | n/a | n/a | 16.2M | 435K | -2M | -5.98M | 164K | 6.89M | 1.91M | -789.32K | 1.56M | n/a |
| Change in Working Capital | n/a | n/a | -466K | -357K | 374K | -5.12M | -2.29M | -1.65M | 3.32M | 87K | 1.46M | 122K | n/a |
| Operating Cash Flow | -69.67M | -33.53M | -18.72M | 10.44M | -1.94M | -23.74M | -54.2M | -33.1M | -29.77M | -20.27M | -14.67M | -4.33M | -4.43M |
| Capital Expenditures | n/a | -296K | -93K | -102K | -33K | -26K | -21K | -181K | -643K | -135K | -48.72K | -51K | -18.94K |
| Acquisitions | n/a | -30.4M | -14.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -41.16M | -45.81M | -22.54M | -15.42M | n/a | n/a | n/a | -27.38M | -89.85M | -19M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 25M | 59.12M | 36.63M | n/a | n/a | 3.26M | 33.35M | 54.97M | 44.65M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -6M | n/a | -36.63M | -15.42M | n/a | 3.26M | 33.35M | 27.59M | -1.1M | -19M | 5K | 17K | 5.07M |
| Investing Cash Flow | -22.16M | -17.39M | -36.72M | -15.52M | -33K | 3.23M | 33.33M | 27.41M | -46.95M | -19.14M | -43.72K | -34K | 5.05M |
| Debt Repayment | 16.29M | 25.59M | 12.78M | -38.1M | 2.86M | 5.24M | -193K | -157K | 62.17M | 3.97M | 24.93M | 3.79M | -79.36K |
| Common Stock Repurchased | n/a | -3.45M | -4.72M | -2.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -65K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.3M | 6.32M | 291K | 104.73M | -118K | -300K | -116K | -46K | -1.01M | -2.44M | -1.93M | n/a | n/a |
| Financial Cash Flow | 82.11M | 28.46M | 8.35M | 113.11M | 2.74M | 4.94M | 28.02M | -203K | 61.16M | 61.47M | 23M | 3.79M | 381.13K |
| Net Cash Flow | -9.26M | -22.42M | -46.88M | 108.02M | 767K | -15.56M | 7.15M | -5.89M | -15.56M | 22.06M | 8.29M | -573K | 2.54M |
| Free Cash Flow | -69.67M | -33.83M | -18.81M | 10.34M | -1.97M | -23.76M | -54.22M | -33.28M | -30.41M | -20.4M | -14.72M | -4.38M | -4.45M |